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ABSTRACT
Introduction. Many physicians recommend annual or biennial visits 
after total hip and knee arthroplasty (THA and TKA). This study 
sought to establish the cost of a post-operative visit to both the health 
care system and patient and identify if these visits altered patient 
management.
Methods. A prospective cohort study was conducted using patients 
presenting for follow-up after THA or TKA from April through 
December 2016. All surgeries were performed by a single orthopaedic 
surgeon in Wichita, Kansas. All eligible subjects that met the inclusion 
criteria received and completed a questionnaire about the personal 
cost of the visit and their assessment of their function and outcome 
after total joint arthroplasty. The physician also completed a ques-
tionnaire that examined the cost of the visit to the health care system 
and whether the clinical or radiographic findings altered patient man-
agement.
Results. Fifty-six patients participated with an average length of fol-
low-up of 4.5 ± 4.1 years since surgery. The average patient cost was 
$135.20 ± $190.53 (range, $1.65 - $995.88), and the average visit time 
for the patient was 3.9 ± 2.9 hours. Eighty percent of patients reported 
no pain during the clinic encounter, and 11% reported loss of function. 
Eighty-four percent thought the visit was necessary. Physician time 
for each visit lasted 12.9 ± 3.7 minutes (range, 10 - 20 minutes). Only 
9% of patient encounters resulted in an alteration in patient manage-
ment. This occurred at an average follow-up time of 3.6 ± 1.8 years 
after the index procedure. The average cost of each visit to the health 
care system at large was $117.31 ± 60.53 (range, $93.90 - $428.28).
Conclusions. The findings of this study advise total joint patients and 
orthopaedic surgeons regarding the cost of routine post-operative 
appointments and whether these visits alter patient management. 
The majority of the routine follow-up visits after THA and TKA did 
not result in an alteration in patient management, but added substan-
tial cost to the health care system. Kans J Med 2018;11(3):59-66.
INTRODUCTION
  Total hip (THA) and knee (TKA) arthroplasty are remarkably 
effective and highly successful surgical treatment options for patients 
with refractory, end-stage hip and knee arthritis.1-9 These operations 
are two of the most common procedures performed by orthopaedic 
surgeons in the United States. Projections estimate that by the year 
2030 the demand for THA will grow 174% to 572,000 per year, while 
the demand for TKA will grow 673% to 3.48 million procedures annu-
ally.10-11 These numbers are expected to rise as patients live longer and 
as these procedures are performed more often in younger (55 years of 
age or less) and more active patients.12-17
 Even though these procedures have shown great success with high 
patient satisfaction rates,18-22 arthroplasty failures continue to remain 
a challenge. Revision THAs and TKAs are costly to the health care 
system and the patient’s overall well-being.23-25 Frequently, patients 
may be asymptomatic before such failure occurs. Timely interven-
tion for patients with asymptomatic complications is beneficial for 
their long-term health outcomes. Therefore, there is a need for close 
post-operative monitoring to detect and manage these complica-
tions before catastrophic failure arises. Many physicians recommend 
routine follow-up after total joint procedures.26 Such follow-up visits, 
however, can be costly for both patient and the health care system. 
Given the overall state of American health care at the present and 
the anticipated rise in the number of joint replacements performed, 
it is imperative to find a cost-effective model for managing patients 
after surgery. One possible source of cost containment includes the 
timing and frequency of follow-up visits to the orthopaedic surgeon 
and the routine use of radiographs. Additionally, the cost to the patient 
is as relevant as those incurred by the system. Elimination of waiting 
and travel time with the associated costs incurred to the patients may 
improve their satisfaction with care.27-32  
 With the improvements in prosthetic design and materials used in 
total joint arthroplasty, revision in asymptomatic patients is uncom-
mon within the first seven years post-operatively;33 therefore, the need 
for annual or biennial routine follow-up of these patients after total 
joint replacement is questioned. To our knowledge, explicit written 
guidelines or standards for long-term THA/TKA follow-up care do 
not exist, although some general references are noted in the litera-
ture.28,34,35 Because of the lack of specific guidelines and studies in the 
U.S. for long-term follow-up, the objective of this study was to assess 
the totality of these costs to the patient, physician, and health care 
system, and determine whether these routine post-operative clinic 
visits alter patient management. By making such determinations, 
potential sources of cost savings for patients and surgeons could be 
identified and employed, improving the clinical decision-making pro-
cesses and enhancing patient satisfaction.
METHODS
 Institutional review board approval was obtained for this pro-
spective cohort study. Subjects were selected from those patients 
presenting for follow-up after THA or TKA from April through 
December 2016 at a single institution by a single board-certified 
orthopaedic surgeon in Wichita, KS. Inclusion criteria consisted of 
patients who underwent either THA or TKA for treatment of primary 
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Exclusion criteria consisted of subjects who were less than one year 
post-operative from THA or TKA, diagnosis of inflammatory arthritis 
or post-traumatic osteoarthritis, prior revision of THA or TKA, previ-
ous joint sepsis, subjects who were being followed at closer intervals 
than typical protocol for concern of THA or TKA failure, and subjects 
whose index arthroplasty was not performed by the lead physician.
 Each eligible subject that volunteered was informed about the 
purpose of the study, and received and signed a consent form upon 
presentation to the orthopaedic clinic for follow-up. Questionnaires 
(Appendix A) completed by subjects had questions pertaining to the 
personal cost of the clinic visit. Issues of interest to the researchers 
were time elapsed since surgery, whether the subject was experienc-
ing pain or loss of function in their joint, how much time the clinic visit 
took from their day, how many miles they drove to their appointment, 
total estimated monetary cost of the visit (includes gas, lost wages, 
co-pays, etc.), whether they had a friend or relative accompanying 
them and the cost of this visit to that person, and whether the visit 
was necessary. The mileage was calculated from the travel distance 
between the subject’s home and clinic using Google Maps, and the 
cost of mileage was calculated using the IRS reimbursement rate for 
mileage driven for medical purposes of $0.235 per mile.
 The lead physician completed a questionnaire (Appendix B) for 
each eligible subject that participated in this study. The physician 
questionnaire investigated the type of total joint arthroplasty, time 
spent on the visit, radiographs or laboratory studies ordered, whether 
the management plan changed because of the visit, and whether the 
physician felt the visit was necessary. The cost of the visit to the phy-
sician and the health care system, including radiographs, laboratory 
studies, and cost of the outpatient visit for a given level (1 - 5) for an 
established patient in a non-facility setting, was determined using the 
Centers for Medicare & Medicaid Services (CMS) 2015 Physician 
Fee Schedule, using the non-facility cost and Kansas locality (Table 1). 
Data collection also included subject demographics information such 
as sex, age, height, weight, body mass index (BMI), surgical procedure 
type, date of surgery, and the subject’s home address.
 Descriptive statistics of the mean, standard deviation, and range 
were determined using the continuous variables of time elapsed since 
surgery, subjects’ demographics (age, height, weight, BMI), estimated 
time of the clinic visit, travel distance, estimated average total cost for 
the patient, physician’s clinic visit time, and estimated average total 
cost for the health care system. Data entry was accomplished using 
Microsoft Excel 2013 (Microsoft, Redmond, WA).
RESULTS
 A total of 58 consecutive subjects participated in the study, of 
which two were excluded based on the inclusion/exclusion criteria. 
The population included 27 females (48%) and 29 males (52%; Table 
2). The average age was 68 ± 10 years (range, 46 - 86 years) with an 
average BMI of 33.58 ± 7.73 (range, 15.66 - 52.61). The average length 
of follow-up since surgery was 4.5 ± 4.1 years (range, 1.0 - 19.3 years). 
Twenty-one (38%) of the 56 patients had more than one total joint 
arthroplasty procedure performed. Forty-one (62%) had TKA and 
19 (29%) had THA. There were five subjects (8%) with bilateral THA 
performed and one subject (2%) had bilateral TKA performed.
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Table 1. Cost data used in current study.
Code Description Cost (USD)*
99211 Level 1 Outpatient Visit, Established Patient 18.62
99212 Level 2 Outpatient Visit, Established Patient 41.03
99213 Level 3 Outpatient Visit, Established Patient 68.71
99214 Level 4 Outpatient Visit, Established Patient 102.17
99215 Level 5 Outpatient Visit, Established Patient 137.99
73510 Radiograph of the hip, unilateral, 2 views 34.05
73520 Radiograph of the hip, bilateral, 2 views 36.40
72170 Radiograph of the pelvis, anterior posterior 25.19
73560 Radiograph of the knee, 1 or 2 views 26.81
73562 Radiograph of the knee, 3 views 31.36
72564 Radiograph of the knee, 4 views 36.58
73565 Radiograph of the knees, bilateral, anterior posterior, 
weight bearing 30.03
78315 Bone scan, 3 phase 328.21
85025 Complete blood count with differential 10.58
85652 Erythrocyte sedimentation rate, automated 3.68
86140 C-reactive protein 4.70
*CMS/Medicare 2015 data, Kansas locality, non-facility price.
Table 2. Patient demographics. 
Total number of patients
Female 27 (48%)
Male 29 (52%)
Mean age (years) 68 ± 10(range, 46 - 86)
Height (inches) 66 ± 4(range, 59 - 74)
Weight (lbs.) 209 ± 52(range, 97 - 346)
BMI (kg/m2) 33.58 ± 7.73(range, 15.66 - 52.61)
Follow-up time (years) 4.5 ± 4.1(range, 1.0 - 19.3)
Number of patients with >1 joint replacement 21 (38%)
Joint type
Hip 19 (29%)
Knee 41 (62%)
Bilateral Hip 5 (8%)
Bilateral Knee 1 (2%)
Overall, the majority of subjects were satisfied with functional out-
comes of their total joint arthroplasty. Forty-five (80%) out of the 
56 subjects reported no pain during the clinic encounter. This result 
indicated improvement (46%) or no change (43%) since their last 
encounter (Table 3). There were a minority of subjects (11%) that 
reported loss of function in their total joint arthroplasty; however, only 
three subjects (5%) stated their function had worsened since their 
last encounter. There were 29 subjects (52%) who reported improve-
ment in function, and 24 subjects (43%) who reported no change in
60
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function. Despite the time and cost of each encounter, the majority of 
subjects (84%) thought that the visit was necessary. There were only 
nine subjects (16%) that thought the visit was unnecessary. For this 
subgroup of patients, there were two female subjects and seven male 
subjects who lived an average of 123.9 ± 172.8 miles (range, 9.4 - 430.0 
miles) away from the clinical site, and their average follow-up time 
was 2.3 ± 1.9 years (range, 1.0 - 5.4 years).
Table 3. Summary results. 
Patient
Feel pain at vist
Yes 11 (20%)
No 45 (80%)
Compare pain 
vs. previous 
visit
Improved 26 (46%)
Worse 6 (11%)
No change 24 (43%)
Loss function
Yes 6 (11%)
No 50 (89%)
Function vs. 
previous visit
Improved 29 (52%)
Worse 3 (5%)
No change 24 (43%)
Visit necessary?
Yes 47 (84%)
No 9 (16%)
Family member 
accompany?
Yes 29 (52%)
No 27 (48%)
Estimated time taken (hour) 3.9 ± 2.9(range, 0.5 - 12.0)
Travel distance (mile) 131.2 ± 158.5(range, 2.6 - 580.0)
Estimated average total cost for 
patient
$135.20 ± $190.53
(range, $165 - $995.88)
Surgeon
Office visit time (minutes) 12.9 ± 3.7(range, 10 - 20)
Alter 
management 
plan
Yes 5 (9%)
No 51 (91%)
Visit necessary?
Yes 5 (9%)
No 51 (91%)
Estimated average total cost for 
health care system
$117.31 ± $60.53
(range, $93.90 - $428.28)
The estimated average cost for the subjects for each encounter 
was $135.20 ± $190.53 (range, $1.65 - $995.88). Each visit, includ-
ing travel time, required 3.9 ± 2.9 hours (range, 0.5 - 12.0) of the 
subjects’ time. The distance traveled for each patient varied consid-
erably, resulting in an average travel distance of 131.2 ± 158.5 miles 
(range, 2.6 - 580.0 miles). There were 29 subjects (52%) who came 
with a companion to the encounter. 
From the physician’s perspective, each visit lasted approximately 
12.9 ± 3.7 minutes (range, 10 - 20 minutes; Table 3).  Out of the 
56 subjects, only five (9%) encounters resulted in an alteration 
in patient management beyond routine follow-up. This occurred 
an average of 3.6 ± 1.8 years (range, 1.1 - 5.3 years) after the index 
procedure. One patient received a three-phase bone scan to rule 
out aseptic loosening. Another patient complained of radiculopa-
thy, and a magnetic resonance imaging (MRI) study of the lumbar 
spine was ordered. A third patient demonstrated clinically signifi-
cant quadriceps weakness, and a lower extremity electromyogram 
and nerve conduction velocity study was ordered. A fourth patient 
complained of symptomatic patellar osteophytes and global insta-
bility. This patient was scheduled for surgery, consisting of open 
osteophyte excision and polyethylene liner exchange. The final 
patient had a laboratory panel ordered to rule out periprosthetic 
infection. For these five subjects, the estimated average cost was 
$155.16 ± $239.18 (range, $6.96 - $577.29) while the cost of these 
appointments to the health care system was $261.78 ± $145.60 
(range, $100.00 - $428.28), and the average cost of each visit to the 
health care system at large was $117.31 ± $60.53 (range, $93.90 - 
$428.28).
DISCUSSION
This study accurately delineated the costs of each clinical en-
counter from a patient and system perspective using prospectively 
gathered data from patient and physician questionnaires. The ma-
jority of patients were satisfied with the pain and function of their 
total joint arthroplasty, which is in line with reported data.36 This 
study accurately assessed patients’ perceptions of the visit in real 
time instead of relying on patient recall during post-visit follow-up 
phone calls, and limiting any recall bias. This study assessed wheth-
er the encounter resulted in any change in management above and 
beyond routine follow-up.
Surveys and questionnaires as a method for developing informa-
tion about clinical practice have been used in many medical special-
ties.37,38 Most patients in this study reported by questionnaire they 
were satisfied with their total joint from a pain and functional stand-
point. The majority (91%) of these follow-up visits were not viewed 
as necessary by the lead surgeon and did not result in an alteration 
in patient management at an average of 4.5 ± 4.1 years (range 1.0 - 
19.3 years) after surgery. These findings contradicted the results of 
prior studies. Teeny et al.26 surveyed 682 members of the American 
Association of Hip and Knee Surgeons and found that the majority 
(80%) of respondents favored annual or biennial visits for un-
complicated total hip and knee arthroplasties. Furthermore, their 
study showed an agreement among members that more frequent 
follow-up may be necessary in the setting previously identified signs 
of early failure, previous joint sepsis, previous revision surgery, and 
poor bone quality. 
Many physicians recommended scheduling routine post-opera-
tive follow-up appointments after primary total joint arthroplasty, 
even if patients are asymptomatic. The objective of routine outpa-
tient assessment of asymptomatic patients is to evaluate and detect 
early signs of failure and to guide recommendations for early inter-
vention. Some issues that factor into this decision-making process 
include implant design, materials, manufacturing methods, implant 
fixation methods, surgical technique, implant shelf life, presence 
of bone grafts,39-43 patient young age,44-46 activity level,47,48 patient’s 
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sepsis,54-56 compromised immune status, and other underlying disease 
processes.45,47 The initial signs of failure detected may be bone loss 
secondary to osteolysis, resulting in more complex revision proce-
dures with higher risks, higher costs, and less successful outcomes. 
Some early signs of failed total joint arthroplasty include an increase 
in pain or a decrease in joint function. Persistent pain and swelling 
may indicate implant-loosening, wear, or infection; the decline in 
joint function may cause a limp, stiffness, or instability. Patients who 
demonstrate these symptoms and signs may require revision joint 
arthroplasty.
Christensen and Folkmar57 performed a retrospective chart 
review study in Denmark to examine whether radiographs at three 
and twelve-month marks post-operatively resulted in any change in 
primary elective cementless THA patient management. Their results 
showed that at three months, only eight (4%) of 216 cases showed 
any subsidence (all cases were <10 mm), and only one out of the eight 
patients was treated with crutches while the others received closer 
follow-up. At 12 months, only two patients (1%) showed stress shield-
ing and were given further follow-up. They concluded that routine 
radiographs in that first year did not offer any benefit and would only 
be warranted when the patient presented with a specific complaint 
regarding their total joint. Hacking et al.33 performed a prospective 
analysis of 110 THAs over a four-year period, and they found that 
only four (3.6%) of the 110 cases were for asymptomatic revisions in 
the first seven years after primary THA. Other studies supported “no 
follow-up” until several years after primary THA.58,59 The findings in 
the present study corroborated these results. In the present study, 
all patients received a clinical and radiographic examination during 
their encounter, but rarely (9%) did this lead to an alteration in care. 
It is no doubt that detection of silent but potentially significant prob-
lems in total joint arthroplasty may be enhanced by regular, periodic 
follow-up, which would allow the impending failure to be detected 
at an earlier stage, thus reduce the increasing health care costs and 
burdens associated with revision THA and TKA. The current practice 
of routine follow-up of asymptomatic THA or TKA, however, may 
be excessive, costly, and unnecessary, and a less resource-intensive 
review method may be more appropriate.
Interestingly, our results indicated that 84% of total joint arthro-
plasty patients preferred routine follow-up. This result contradicted 
reports from a study performed by Sethuraman et al,28 which looked at 
100 asymptomatic or minimally symptomatic total joint arthroplasty 
patients with two or more years prior between June 1998 and October 
1998. Their results showed that nearly half of their patients preferred 
to avoid the routine follow-up secondary to lost time and wages, and 
patient-provider telephone care was preferred. One possible expla-
nation for this disparity is due to pre-operative patient education. 
Pre-operatively, most patients are informed, either by their surgeon or 
the internet, that they will need routine annual or biennial follow-up 
to ensure they are not developing any post-operative complications. 
Many of these patients, including those without symptoms, may feel 
these visits are crucial in preventing catastrophic problems with 
their total joint. Educating patients regarding early signs and symp-
toms of total joint arthroplasty failure is crucial if physicians plan to 
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eliminate early routine follow-up visits in the first few years after 
surgery when patients are less likely to develop these complications. 
Patient education, such as the benefit of proper diet, acceptable 
levels of post-arthroplasty exercise, and smoking cessation, should be 
emphasized. Tobacco has been shown to hinder bone healing. Alcohol 
consumption (beer, liquor, or wine) of three or more units per day 
will have consequential effects on bone health, leading to lower bone 
mineral density when compared with more moderate drinking.60 
Education on avoidance of preventable falls also has a major impact 
on reducing further periprosthetic and fragility fractures, especially 
in patients with osteoporosis who often experience muscle weakness, 
postural deformity, and poor balance.61 Patients who undergo tailored 
exercises and intervention have a decrease in fall rate in the communi-
ty.62 These measures with appropriate patient education could reduce 
the need for routine early follow-up after a total joint arthroplasty.
The cost to the patient is as relevant as those incurred by the health 
care system. Elimination of waiting and travel time with the asso-
ciated costs incurred to the patients may improve their satisfaction 
with care.29-32 Sethuraman et al.28 reported their patient population 
could have saved wages averaging $135 for each clinic visit in Phila-
delphia, PA in 1998. This study also determined a similar average cost 
to the patient. In the present study, the average cost was $135.20 ± 
$190.53 (range, $1.65 - $995.88). In the Midwest, such variation is 
not unexpected when one considers the geographical area orthopae-
dic surgeons may serve. 
When factoring in the driving time and distance along with lost 
wages, it makes it easier to recognize how such a visit may prove more 
expensive for a patient living further away than for another residing 
in the same zip code. For this reason, telemedicine may become an 
option for the future. Patients could have x-rays taken at their local 
hospital or primary care provider’s office and have the imaging sent 
to their surgeon for review, followed by a telemedicine encounter to 
discuss how the patient’s total joint is performing. However, telemedi-
cine is only a virtual interaction. The encounter would be missing 
the physical examination component, which is an important part of 
the evaluation process. Without it, there exists the possibility that 
certain issues could be missed. To our knowledge, no studies have 
been performed comparing the efficacy of telemedicine interactions 
compared to traditional patient encounters concerning detection 
of complications after total hip or knee arthroplasty. Such research, 
however, could represent an area of future study for follow-up of total 
hip and knee arthroplasty patients. 
As health care costs increase, more emphasis has been placed 
on cost containment. The numbers generated in our study repre-
sent one possible source of savings to the health care system. Bolz 
et al.27 used a decision-analytic Markov model to compare the costs 
and health outcomes of three follow-up strategies after primary 
total joint arthroplasty and demonstrated that without routine fol-
low-up for the first seven years after surgery, there would be a total 
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savings to the system of $11.9 million and gains of between 1.8 to 8.8 
quality-adjusted life years for patients. However, it is important to 
temper the goal of cost savings by balancing with it a need to provide 
satisfactory patient care. Identifying pre-operatively which patients 
may wish to have routine post-operative visits and benefit from them 
versus those that would prefer less frequent follow-up intervals, may 
allow for a strategy in which health care costs are decreased while 
concomitantly increasing patient satisfaction. 
Several concerns may be raised regarding the validity of our model 
and applying our results to the management of routine follow-up visits 
after total joint procedures. The most significant limitation in this 
study was small sample size, and the patients were drawn only from 
one local physician. This prevented application of tests of significance 
due to insufficient power. The low number of subjects participating 
was unavoidable because the office staff of the lead physician experi-
enced a high turnover rate during the data collection period. Repeating 
this study with a larger number of enrollees would be beneficial, thus 
making the data more reliable for a treatment analysis. This would be 
beneficial to practitioners deciding on how to manage post-operative 
follow-up after total joint arthroplasty. Another limitation was that 
the physician reviewing the prospective group was not blinded to the 
purpose of the study. This situation could introduce a collection bias 
that might underestimate the importance of routine post-operative 
follow-up. Another weakness was that the cost determinations were 
only estimates based on Medicare reimbursement rates for billed 
CPT codes. The present study did not collect data regarding patients’ 
insurance policies. It was likely that several patients had insurance 
other than Medicare that paid for their health care. Our estimated 
costs may not reflect the true amount the facility billed, nor what was 
paid by the insurer. The cost to the patient was only an estimate based 
on patients’ travel distance to and from the clinic and potential lost 
wages of both themselves and their companions. 
Additionally, this study identified a discrepancy between patients 
and the physician regarding the usefulness of each post-operative 
visit. However, the questionnaires did not explore the rationale behind 
these beliefs. Examining these thoughts could identify the etiology 
behind the difference and provide physicians with a better under-
standing of their patients’ psyches, thus improving the doctor-patient 
relationship. Despite these limitations, our data were valid. Further 
research using a larger study population with multiple surgeons and 
employing a cost-effectiveness model is needed, and subjects should 
be followed prospectively at each post-operative visit to support and 
expand upon our findings further.
CONCLUSION
In summary, this study illustrated that the majority of post-opera-
tive follow-up visits, especially for those asymptomatic patients, did 
not result in an alteration in patient management, but added sub-
stantial cost to the health-care system. Future studies are needed to 
determine, fully and accurately, the cost-effectiveness of these visits 
and how many patients must be seen routinely to prevent total joint 
failure.
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